Host Nuclear Factor-κB Activation Potentiates Lung Cancer Metastasis

Georgios T. Stathopoulos,Taylor P. Sherrill,Wei Han,Fluxana T. Sadikot,Fiona E. Yull,Timothy S. Blackwell,Barbara Fingleton

DOI: https://doi.org/10.1158/1541-7786.mcr-07-0309

2008-01-01

Molecular Cancer Research

Abstract:Epidemiologic and experimental evidence suggests that a link exists between inflammation and cancer, although this relationship has only recently begun to be elucidated for lung cancer, the most frequently fatal human tumor. Nuclear factor-κB (NF-κB), a transcription factor that controls innate immune responses in the lungs, has been implicated as an important determinant of cancer cell proliferative and metastatic potential; however, its role in lung tumorigenesis is uncertain. Here, we specifically examine the role of NF-κB–induced airway inflammation in lung cancer metastasis using a model of intravenous injection of Lewis lung carcinoma cells into immunocompetent C57Bl/6 mice. Induction of lung inflammation by direct and specific NF-κB activation in airway epithelial cells potentiates lung adenocarcinoma metastasis. Moreover, we identify resident lung macrophages as crucial effectors of lung susceptibility to metastatic cancer growth. We conclude that NF-κB activity in host tissue is a significant factor in the development of lung metastasis. (Mol Cancer Res 2008;6(3):364–71)